Key risks - delay in resolution of Goa WL, lower-than-expected growth in India and South Africa, trade margin cap in India, higher price erosion in the US and delay in key US approvals. Cipla received approval for gProventil HFA (Albuterol Sulfate), its first MDI (metered dose inhaler) approval in the US. This is the first generic approved by the US FDA for Proventil HFA. The approval comes ahead of time (was expected in 2HFY21) as FDA recognizes the rising demand for albuterol products during coronavirus pandemic.